Advertisement
Advertisement
RLMD
Relmada Therapeutics, Inc. Common Stock
3.78
USDSponsored
-0.46
-10.85%
Sep 23, 15:59 UTC -4
Closed
After-Market
3.75
-0.03
-0.77%
Relmada Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 400.12M |
| Beta | 0.45 |
| Earnings Per Share (EPS) | -0.90 |
| Price-to-Book (P/B) Ratio | 2.11 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -47.52% |
| Current Ratio | 29.52% |
| Free Cash Flow | -24.67M |
